Atlas Trials

Safety Study in Volunteers From 16 to 65 Years of Age: FSME IMMUN NEW vs. ENCEPUR

Clinical trial NCT00161824 · COMPLETED

Trial details

NCT number
NCT00161824
Sponsor
Pfizer
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Encephalitis, Tick-borne
Start date
2001-10-01
Enrollment
3800

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.